- Home
- FSTR vs MNPR Comparison
FSTR vs MNPR Comparison
Compare FSTR & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSTR
- MNPR
- Stock Information
- Founded
- FSTR 1902
- MNPR 2014
- Country
- FSTR United States
- MNPR United States
- Employees
- FSTR N/A
- MNPR N/A
- Industry
- FSTR Metal Fabrications
- MNPR Biotechnology: Pharmaceutical Preparations
- Sector
- FSTR Industrials
- MNPR Health Care
- Exchange
- FSTR Nasdaq
- MNPR Nasdaq
- Market Cap
- FSTR 209.9M
- MNPR 249.5M
- IPO Year
- FSTR N/A
- MNPR 2019
- Fundamental
- Price
- FSTR $18.89
- MNPR $31.73
- Analyst Decision
- FSTR Hold
- MNPR Strong Buy
- Analyst Count
- FSTR 1
- MNPR 5
- Target Price
- FSTR $25.00
- MNPR $59.50
- AVG Volume (30 Days)
- FSTR 28.3K
- MNPR 18.2K
- Earning Date
- FSTR 05-06-2025
- MNPR 05-13-2025
- Dividend Yield
- FSTR N/A
- MNPR N/A
- EPS Growth
- FSTR 361.43
- MNPR N/A
- EPS
- FSTR 3.34
- MNPR N/A
- Revenue
- FSTR $504,237,000.00
- MNPR N/A
- Revenue This Year
- FSTR $4.49
- MNPR N/A
- Revenue Next Year
- FSTR $3.64
- MNPR N/A
- P/E Ratio
- FSTR $5.66
- MNPR N/A
- Revenue Growth
- FSTR N/A
- MNPR N/A
- 52 Week Low
- FSTR $14.23
- MNPR $1.72
- 52 Week High
- FSTR $29.78
- MNPR $54.30
- Technical
- Relative Strength Index (RSI)
- FSTR 45.90
- MNPR 37.28
- Support Level
- FSTR $18.18
- MNPR $34.02
- Resistance Level
- FSTR $19.56
- MNPR $36.82
- Average True Range (ATR)
- FSTR 0.59
- MNPR 3.54
- MACD
- FSTR 0.04
- MNPR -0.71
- Stochastic Oscillator
- FSTR 44.10
- MNPR 27.91
About FSTR L.B. Foster Company
L.B. Foster Co is a us-based firm engaged in the manufacturing, fabrication, and distribution of products and services, especially for the rail, construction, energy, and utility industries. The company operates its business through two segments: Rail Technologies and Services and Infrastructure Solutions. Its principal business activity involves providing new and used rail, trackwork, and accessories, producing concrete railroad ties, insulated rail joints, power rail, track fasteners, cover boards, and sales of sells and rents steel sheet piling, H-bearing pile, and other piling products for foundation and earth retention requirements. It generates the majority of its revenues from the Rail Technologies and Services segment.
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.